iodonitrotetrazolium has been researched along with rivaroxaban in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chantarangkul, V; Guinet, C; Samama, MM; Tripodi, A | 1 |
1 other study(ies) available for iodonitrotetrazolium and rivaroxaban
Article | Year |
---|---|
The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study.
Topics: Blood Coagulation; Calibration; Drug Monitoring; Factor Xa Inhibitors; Feasibility Studies; Fibrinolytic Agents; Humans; Morpholines; Prothrombin Time; Reference Standards; Rivaroxaban; Tetrazolium Salts; Thiophenes; Thromboplastin | 2011 |